Atlas Trials

A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food

Clinical trial NCT07404137 · COMPLETED

Trial details

NCT number
NCT07404137
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2026-02-16
Primary completion
2026-04-02
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.